# US 2010/0168238 A1 · Pharmaceutical composition containing phloroglucinol and paracetamol

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0168238 A1
- Document ID: US20100168238A1
- Status: Published application
- Kind: A1
- Application number: 12/527,592
- Filed: 2008-02-18
- Published: 2010-07-01
- Earliest claimed: 2007-02-19
- Assignees: Promindus (Actions Promotionnelles Dans l'Industrie et le Commerce)
- Inventors: Jean-Jacques Serrano; Claudette Serrano
- Web page: https://patentgrep.com/patent/US20100168238A1

## CPC

- A61K 31/167: having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
- A61K 9/0007: {Effervescent (A61K9/0065 takes precedence)}
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61P 1/06: Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
- A61P 21/00: Drugs for disorders of the muscular or neuromuscular system
- A61P 25/08: Antiepileptics; Anticonvulsants
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The invention relates to a pharmaceutical composition for oral or rectal administration, that contains phloroglucinol and paracetamol in a pharmaceutically acceptable carrier. The inventors have evidenced a synergy developed by these two active ingredients in antispasmodic therapy.

## Claims

### Claim 1

A pharmaceutical composition for oral or rectal administration, comprising phloroglucinol, paracetamol, and a pharmaceutically acceptable excipient.

### Claim 2 (depends on 1)

The pharmaceutical composition as claimed in claim 1, wherein the composition is in a form selected from the group consisting of tablets, capsules, powders, granules, lyophilizates, oral solutes, syrups, suspensions and suppositories.

### Claim 3 (depends on 1)

The pharmaceutical composition as claimed in claim 1 wherein the composition is in the form of an effervescent tablet.

### Claim 4 (depends on 3)

The pharmaceutical composition as claimed in claim 3, wherein
the effervescent tablet further comprises
at least one organic acid and/or at least one salt of an organic acid, said organic acid being selected from the group consisting of citric acid, tartaric acid, malic acid and acetic acid, and
at least one strong base and/or at least one salt of a strong base, said at least one salt of a strong base being selected from the group consisting of sodium bicarbonate, sodium carbonate, calcium bicarbonate, calcium carbonate, magnesium bicarbonate, magnesium carbonate, potassium bicarbonate and potassium carbonate.

### Claim 5 (depends on 1)

The pharmaceutical composition as claimed in claim 1, wherein the phloroglucinol is present at a dose of between 50 and 200 mg.

### Claim 6 (depends on 1)

The pharmaceutical composition as claimed in claim 1, wherein the paracetamol is present at a dose of between 100 and 1000 mg.

### Claim 7

(canceled)

### Claim 8

(canceled)

### Claim 9

(canceled)

### Claim 10 (depends on 5)

The pharmaceutical composition of claim 5, wherein the phloroglucinol is present at a dose of 80, 100 or 160 mg.

### Claim 11 (depends on 5)

The pharmaceutical composition of claim 5, wherein the paracetamol is present at a dose of between 100 and 500 mg.

### Claim 12 (depends on 1)

A method of treating a spasmodic condition comprising administering a therapeutically effective amount of a pharmaceutical composition according to claim 1 to the patient.

### Claim 13 (depends on 12)

The method of claim 12, wherein the spasmodic condition is spastic colitis, hepatic colic, nephritic colic, or dysmenorrheal.
